Vapotherm (VAPO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Signed definitive merger agreement to go private, led by an affiliate of Perceptive Advisors and Perceptive Discovery Fund.
SLR Capital Partners to convert $81M of term debt into preferred equity; Perceptive to invest $50M in new preferred equity.
Stockholders to receive $2.18 per share in cash, a 166% premium over the last closing price before announcement.
Transaction expected to close in the second half of 2024, subject to customary conditions including stockholder approval.
Upon completion, the company will become private and delist from OTCQX.
Voting matters and shareholder proposals
Stockholders will vote on the adoption of the merger agreement and approval of the transaction.
A special committee of independent directors unanimously recommended the merger to the board and stockholders.
Proxy statement and Schedule 13E-3 will be filed and distributed to stockholders for voting decisions.
Board of directors and corporate governance
Special committee comprised solely of independent directors advised by an independent financial advisor.
Board acted on the special committee's recommendation to approve the merger.
Latest events from Vapotherm
- Shareholders to vote on $2.18/share cash merger; board unanimously recommends approval.VAPO
Proxy Filing1 Dec 2025 - Shareholders to receive $2.18 per share in cash as part of a going-private merger, with Board support.VAPO
Proxy Filing1 Dec 2025 - Shareholders to vote on a $2.18/share cash merger, with board and special committee unanimous support.VAPO
Proxy Filing1 Dec 2025 - Loan agreement amendment increases credit facility, revises terms, and aligns with merger closing.VAPO
Proxy Filing1 Dec 2025 - Merger to go private offers $2.18/share, SLR majority ownership, and $50M Perceptive investment.VAPO
Proxy Filing1 Dec 2025 - Merger to go private offers $2.18/share, new equity, and board changes with SLR and Perceptive.VAPO
Proxy Filing1 Dec 2025 - Merger agreement to go private, raise equity, and restructure debt pending stockholder vote.VAPO
Proxy Filing1 Dec 2025 - Merger and new funding announced; stockholder vote and proxy materials forthcoming.VAPO
Proxy Filing1 Dec 2025 - Revenue up 5.3% and margins improved, but net loss and liquidity risks remain significant.VAPO
Q2 202413 Jun 2025